期刊
TRENDS IN MOLECULAR MEDICINE
卷 19, 期 11, 页码 643-654出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2013.07.005
关键词
nucleolus; nucleolar stress; p53; ribosomal gene transcription; RNA polymerase I inhibitor; cancer therapy
资金
- National Health and Medical Research Council (NHMRC) of Australia
- Leukaemia Foundation
- Prostate Cancer Foundation of Australia
- NHMRC
For over 100 years, pathologists have utilised an increase in size and number of nucleoli, the subnuclear site of ribosome synthesis, as a marker of aggressive tumours. Despite this, the contribution of the nucleolus and ribosomal RNA synthesis to cancer has been largely overlooked. This concept has recently changed with the demonstration that the nucleolus indirectly controls numerous other cellular function's, in particular, the cellular activity of the critical tumour suppressor protein, p53. Moreover, selective inhibition of ribosomal gene transcription in the nucleolus has been shown to be an effective therapeutic strategy to promote cancer-specific activation of p53. This article reviews the largely untapped potential of the nucleolus and ribosomal gene transcription as exciting new targets for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据